Correction: Targeted Inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.
Saved in:
| Title: | Correction: Targeted Inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications. |
|---|---|
| Authors: | Zhao, Bixing1,2 (AUTHOR), Zhou, Yang1,2 (AUTHOR), Cheng, Niangmei1,2 (AUTHOR), Zheng, Xiaoyuan1,2 (AUTHOR), Chen, Geng1,2 (AUTHOR), Qi, Xin1,2 (AUTHOR), Zhang, Xiangzhi1,2 (AUTHOR), Wang, Fei1,2 (AUTHOR), Zhuang, Qiuyu1,2 (AUTHOR), Assaraf, Yehuda G.3 (AUTHOR) assaraf@technion.ac.il, Liu, Xiaolong1,2 (AUTHOR) xiaoloong.liu@gmail.com, Wang, Yingchao1,2 (AUTHOR) yingchaowang@live.com, Zeng, Yongyi1,2 (AUTHOR) lamp197311@126.com |
| Source: | Journal of Experimental & Clinical Cancer Research (17569966). 5/26/2025, Vol. 44 Issue 1, p1-4. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17569966 |
|---|---|
| DOI: | 10.1186/s13046-025-03423-6 |
